The Latest Breaking News from MAPS

Hundreds of P&O Ferries workers laid off last month are in danger of switching their retirement funds into less generous alternatives, financial experts are warning

This article by Freddie Earlam was originally published on Microdose and appears here with permission. If the industry-defining research already conducted at UK centers such as Imperial College, King’s college or even Exeter University’s recent Ketamine Research isn’t enough to convince you, then two more crucial factors surely will. Firstly, a new ‘accelerated pathway’ has…

What Happened: According to the Multidisciplinary Association of Psychedelic Studies (MAPS), a non-profit organization, the FDA is close to greenlighting MDMA as a treatment for PTSD. MAPS reported positive results from a phase-3 trial testing the efficacy of MDMA-assisted therapy.

Numinus Wellness Inc. (OTCQX:NUMIF), announced that clinical trial MAPPUSX has gotten underway with the enrolling and dosing of the first trial volunteer in Canada. MAPPUSX, which stands for "A multi-site open-label extension study of MDMA-assisted psychotherapy for PTSD”, is sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS) and organized by…

This article was originally published on Psychedelic Spotlight and appears here with permission. While psychedelic studies now number in the thousands since Western research began in the 1950s, we unpack five of the most important in recent years as psychedelics are on the cusp of becoming mainstream medicines. When it…

This article was originally published on Psychedelic Spotlight and appears here with permission. Multidisciplinary Association for Psychedelic Studies (MAPS) published a study which found that MDMA-assisted therapy significantly reduced symptoms of eating disorders. Anyone who has ever suffered from an eating disorder, such as anorexia or bulimia, knows that beating…

These 15 tips and tricks can enhance Apple Maps and make sure you get the most out of it.

A new company has entered the public psychedelic markets, with an alternative drug-to-market approach. Using Real World Evidence trials, Albert Labs is expecting to legally provide psilocybin to patients in the UK much earlier than companies working with to get FDA approval.

WM Technology, Inc. (NASDAQ: MAPS), a leading marketplace and technology solutions provider to the cannabis industry, announced on Thursday that it had appointed Anthony Bay as the new chairman of the Company's Board of Directors.

Michael Mullette, a former Moderna (NASDAQ:MNRA) vice president is taking a senior leadership position in the MAPS Public Benefit Corporation, a biotech company in the psychedelics sector. The MAPS PCB is a for-profit company wholly owned by the Multidisciplinary Association for Psychedelic Studies, a nonprofit founded in 1986 to advance patient…

WM Technology, Inc.  (NASDAQ: MAPS), a marketplace and technology solutions provider to the cannabis industry, released its e